These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3306384)

  • 41. Posaconazole-Induced Adrenal Insufficiency in a Case of Chronic Myelomonocytic Leukemia.
    Miller A; Brooks LK; Poola-Kella S; Malek R
    Case Rep Endocrinol; 2018; 2018():2170484. PubMed ID: 29568655
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diabetes in Cushing Disease.
    Mazziotti G; Formenti AM; Frara S; Maffezzoni F; Doga M; Giustina A
    Curr Diab Rep; 2017 May; 17(5):32. PubMed ID: 28364356
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Updates on the role of adrenal steroidogenesis inhibitors in Cushing's syndrome: a focus on novel therapies.
    Fleseriu M; Castinetti F
    Pituitary; 2016 Dec; 19(6):643-653. PubMed ID: 27600150
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ACTH Antagonists.
    Clark AJ; Forfar R; Hussain M; Jerman J; McIver E; Taylor D; Chan L
    Front Endocrinol (Lausanne); 2016; 7():101. PubMed ID: 27547198
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiglucocorticoids as Treatments for Depression : Rationale for Use and Therapeutic Potential.
    Price LH; Malison RT; McDougle CJ; Pelton GH
    CNS Drugs; 1996 May; 5(5):311-20. PubMed ID: 26071044
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Treatment of Cushing's Disease.
    Pivonello R; De Leo M; Cozzolino A; Colao A
    Endocr Rev; 2015 Aug; 36(4):385-486. PubMed ID: 26067718
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Medical therapy for Cushing's disease: adrenal steroidogenesis inhibitors and glucocorticoid receptor blockers.
    Fleseriu M; Petersenn S
    Pituitary; 2015 Apr; 18(2):245-52. PubMed ID: 25560275
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term low-dose ketoconazole treatment in bilateral macronodular adrenal hyperplasia.
    Comte-Perret S; Zanchi A; Gomez F
    Endocrinol Diabetes Metab Case Rep; 2014; 2014():140083. PubMed ID: 25535576
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ketoconazole inhibits ovulation as a result of arrest of follicular steroidogenesis in the rat ovary.
    Gal M; Orly J
    Clin Med Insights Reprod Health; 2014; 8():37-44. PubMed ID: 24987273
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasia.
    Raff H; Sharma ST; Nieman LK
    Compr Physiol; 2014 Apr; 4(2):739-69. PubMed ID: 24715566
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular basis of pharmacological therapy in Cushing's disease.
    Ferone D; Pivonello C; Vitale G; Zatelli MC; Colao A; Pivonello R
    Endocrine; 2014 Jun; 46(2):181-98. PubMed ID: 24272603
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recent developments in drug therapy for Cushing's disease.
    van der Pas R; de Herder WW; Hofland LJ; Feelders RA
    Drugs; 2013 Jun; 73(9):907-18. PubMed ID: 23737437
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combination therapy for Cushing's disease: effectiveness of two schedules of treatment: should we start with cabergoline or ketoconazole?
    Barbot M; Albiger N; Ceccato F; Zilio M; Frigo AC; Denaro L; Mantero F; Scaroni C
    Pituitary; 2014 Apr; 17(2):109-17. PubMed ID: 23468128
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mifepristone: is there a place in the treatment of Cushing's disease?
    Carmichael JD; Fleseriu M
    Endocrine; 2013 Aug; 44(1):20-32. PubMed ID: 23192246
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Medical management of Cushing's disease: what is the future?
    Fleseriu M; Petersenn S
    Pituitary; 2012 Sep; 15(3):330-41. PubMed ID: 22674211
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment Options in Cushing's Disease.
    Rizk A; Honegger J; Milian M; Psaras T
    Clin Med Insights Oncol; 2012; 6():75-84. PubMed ID: 22346367
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human immunodeficiency virus/acquired immunodeficiency syndrome and infertility: emerging problems in the era of highly active antiretrovirals.
    Kushnir VA; Lewis W
    Fertil Steril; 2011 Sep; 96(3):546-53. PubMed ID: 21722892
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of Cushing disease: overview and recent findings.
    Mancini T; Porcelli T; Giustina A
    Ther Clin Risk Manag; 2010 Oct; 6():505-16. PubMed ID: 21063461
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of endocrine manifestations and the use of mitotane as a chemotherapeutic agent for adrenocortical carcinoma.
    Veytsman I; Nieman L; Fojo T
    J Clin Oncol; 2009 Sep; 27(27):4619-29. PubMed ID: 19667279
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of the nuclear receptor DAF-12 as a therapeutic target in parasitic nematodes.
    Wang Z; Zhou XE; Motola DL; Gao X; Suino-Powell K; Conneely A; Ogata C; Sharma KK; Auchus RJ; Lok JB; Hawdon JM; Kliewer SA; Xu HE; Mangelsdorf DJ
    Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9138-43. PubMed ID: 19497877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.